1 | 6Y1Z |
5-hydroxytryptamine receptor 3A | Mus musculus |
P23979 (5HT3A_MOUSE) |
(3~{a}~{S})-2-[(3~{S})-1-azabicyclo[2.2.2]octan-3-yl]-3~{a},4,5,6-tetrahydro-3~{H}-benzo[de]isoquinolin-1-one |
O7B |
|
0.86 |
SHOW |
2 | 6HIS |
5-hydroxytryptamine receptor 3A | Mus musculus |
P23979 (5HT3A_MOUSE) |
(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-INDOLE-3-CARBOXYLATE |
TKT |
|
0.8 |
SHOW |
3 | 5OAJ |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-INDOLE-3-CARBOXYLATE |
TKT |
|
0.53 |
SHOW |
4 | 2WNC |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-INDOLE-3-CARBOXYLATE |
TKT |
|
0.52 |
SHOW |
5 | 2YME |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide |
CWB |
|
0.52 |
SHOW |
6 | 5LXB |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
palonosetron |
7A9 |
|
0.5 |
SHOW |
7 | 4WV9 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(3-exo)-8,8-dimethyl-3-[4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl]-8-azoniabicyclo[3.2.1]octane |
MD4 |
|
0.5 |
SHOW |
8 | 5O8T |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.48 |
SHOW |
9 | 3RQW |
Gamma-aminobutyric-acid receptor subunit beta-1 | Dickeya dadantii |
E0SJQ4 (E0SJQ4_DICD3) |
ACETYLCHOLINE |
ACH |
|
0.48 |
SHOW |
10 | 5OAL |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.48 |
SHOW |
11 | 2Y57 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1R,5S)-8-PHENETHYL-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V37 |
|
0.47 |
SHOW |
12 | 5Y2Q |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
3-[[4-[(3,4-dichlorophenyl)methyl]piperidin-4-yl]methoxy]pyridine |
8L3 |
|
0.46 |
SHOW |
13 | 5OBH |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(5S)-6,6-dimethyl-5-[(6R)-8-oxo-6,8-dihydrofuro[3,4-e][1,3]benzodioxol-6-yl]-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-6-ium |
J94 |
|
0.46 |
SHOW |
14 | 3U8L |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
1-(5-phenylpyridin-3-yl)-1,4-diazepane |
09Q |
|
0.45 |
SHOW |
15 | 4BQT |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE |
C5E |
|
0.45 |
SHOW |
16 | 5BP0 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
5-fluoronicotine |
FN1 |
|
0.45 |
SHOW |
17 | 1UW6 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.45 |
SHOW |
18 | 1UV6 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
2-[(AMINOCARBONYL)OXY]-N,N,N-TRIMETHYLETHANAMINIUM |
CCE |
|
0.45 |
SHOW |
19 | 5OA0 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.45 |
SHOW |
20 | 2Y56 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1S,5R)-8-[(2R)-2-HYDROXY-2-PHENYL-ETHYL]-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V11 |
|
0.44 |
SHOW |
21 | 5O87 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.44 |
SHOW |
22 | 2XZ6 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-(TRIMETHYLAMMONIUM)ETHYL THIOL |
ETM |
|
0.44 |
SHOW |
23 | 3WIP |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
ACETYLCHOLINE |
ACH |
|
0.44 |
SHOW |
24 | 1Q0Y |
Ig lambda-1 chain V regions MOPC 104E/RPC20/J558/S104 | Mus musculus |
P01724 (LV1B_MOUSE) |
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL |
MOI |
|
0.44 |
SHOW |
25 | 5AFK |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.44 |
SHOW |
26 | 5AFH |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.43 |
SHOW |
27 | 5AIN |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
VARENICLINE |
QMR |
|
0.43 |
SHOW |
28 | 5AFL |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.43 |
SHOW |
29 | 2XYS |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
STRYCHNINE |
SY9 |
|
0.43 |
SHOW |
30 | 5BRX |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(2R,3S,5R,7S)-2-(pyridin-3-yl)-1-azatricyclo[3.3.1.1~3,7~]decane |
TI4 |
|
0.43 |
SHOW |
31 | 2XNV |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
2-(2-(4-PHENYLPIPERIDIN-1-YL)ETHYL)-1H-INDOLE |
VU3 |
|
0.43 |
SHOW |
32 | 3ZDG |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
3-(dimethylamino)butyl dimethylcarbamate |
XRX |
|
0.43 |
SHOW |
33 | 6SGV |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
Hosieine |
LDQ |
|
0.43 |
SHOW |
34 | 5AFJ |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.43 |
SHOW |
35 | 5AFM |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.42 |
SHOW |
36 | 5SYO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-8-ONE |
C5E |
|
0.42 |
SHOW |
37 | 6PUF |
Major histocompatibility complex class I-related gene protein | Homo sapiens |
Q95460 (HMR1_HUMAN) |
1-deoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol |
2LJ |
|
0.42 |
SHOW |
38 | 5AFN |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
Alpha-Lobeline |
L0B |
|
0.42 |
SHOW |
39 | 4AFT |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
VARENICLINE |
QMR |
|
0.42 |
SHOW |
40 | 2YK1 |
Fab fragment heavy chain | Homo sapiens |
- |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.42 |
SHOW |
41 | 4UM1 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
1-(5-ethoxypyridin-3-yl)-1,4-diazepane |
09P |
|
0.42 |
SHOW |
42 | 3ZDH |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2R)-N,N-dimethyl-4-(1-methylimidazol-2-yl)oxy-butan-2-amine |
XRS |
|
0.42 |
SHOW |
43 | 5KZU |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
9-[[1-[8-methyl-8-(2-phenylethyl)-8-azoniabicyclo[3.2.1]octan-3-yl]triazol-4-yl]methyl]carbazole |
74S |
|
0.41 |
SHOW |
44 | 4UM3 |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
1-(6-bromopyridin-3-yl)-1,4-diazepane |
09R |
|
0.41 |
SHOW |
45 | 5KXI |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.41 |
SHOW |
46 | 6SH0 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
1-[(1R,6R)-9-azabicyclo[4.2.1]non-2-en-2-yl]ethanone |
4P0 |
|
0.41 |
SHOW |
47 | 2XZ5 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
ACETYLCHOLINE |
ACH |
|
0.41 |
SHOW |
48 | 6CNK |
Neuronal acetylcholine receptor subunit alpha4beta-2 | Homo sapiens |
P17787 (ACHB2_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.41 |
SHOW |
49 | 4ZRU |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
3-[(2S)-pyrrolidin-2-ylethynyl]pyridine |
TI9 |
|
0.41 |
SHOW |
50 | 6PV7 |
Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens |
P32297 (ACHA3_HUMAN) |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
|
0.41 |
SHOW |